Silver-impregnated occlusive dressing is associated with a lower rate of acute surgical site infection after direct anterior total hip arthroplasty - Summary - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Use of Silver-Infused Occlusive Dressings Linked to Reduced Incidence of Acute Surgical Site Infections Following Direct Anterior Total Hip Arthroplasty
To evaluate whether the use of a silver-impregnated occlusive dressing is associated with a lower incidence of acute surgical site infection compared with standard sterile dressing in patients undergoing direct anterior total hip arthroplasty.
Approach:
Patient Selection: Retrospective review of 321 patients who underwent primary THA via DAA from September 2020 to December 2025, excluding certain cases to mitigate early learning-curve effects.
Surgical Technique: All procedures performed by a single surgeon using a lateralized incision to reduce inguinal fold contact.
Dressing Protocol: Standard sterile gauze was used until August 2021, after which AQUACEL® Ag SURGICAL was implemented, with dressing changes every 7 days.
Outcome Measures: Primary outcome was acute surgical site infection within 30 days; secondary outcomes included periprosthetic joint infection and return to OR for wound-related complications within 90 days.
Data Analysis: Data analyzed using IBM SPSS Statistics; comparisons made using appropriate statistical tests.
Key Findings:
The use of silver-impregnated occlusive dressings was associated with a lower incidence of acute surgical site infections compared to standard sterile dressings.
The study included a total of 321 patients with a follow-up period of at least three months.
These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.